November 11, 2026 · The New England journal of medicine · DOI: 10.1056/NEJMoa2602435

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

Listen to this summary

This randomized comparative-effectiveness trial asked whether aspirin is noninferior to warfarin or rivaroxaban for preventing venous thromboembolism (VTE) and death after hip or knee arthroplasty. Among 15,317 patients analyzed, the 6-month composite of death or symptomatic VTE occurred in 1.26% with aspirin, 1.01% with warfarin, and 0.94% with rivaroxaban, and aspirin did not meet the noninferiority criterion for effectiveness. Warfarin and rivaroxaban also did not show noninferior safety compared with aspirin, as their rates of bleeding, wound reoperation, or myocardial infarction were numerically higher.

Vincent D Pellegrini, Carol A Lambourne, Laurence S Magder, Patricia D Franklin, Jay S Magaziner, Brook I Martin, Richard Iorio, Kevin L Garvin, Michael A Mont, Wayne E Moschetti, Antonia F Chen, David Warwick, C McCollister Evarts, Adina Harri, Laura M Kernan, Samuel Z Goldhaber, William J Maloney, Zeke J Walton, James A Browne, Harry A Demos, James I Huddleston, Stephen L Kates, Peter J Brooks, Navin D Fernando, Brock A Lindsey, Matthew J Dietz, James Nace, Ronald E Delanois, Michael S Kain, Mark J Spangehl, Brent A Lanting, Eric M Cohen, Lisa K Moores, William L Healy, Charles W Francis

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play